In relationship banking the emphasis is on establishing a long-term multiple-service relationship; on satisfying the totality of the client's financial service needs; and on minimizing the need or desire of clients to splinter their financial business among various institutions.
Implicit within any definition of relationship banking is recognition that the financial-service requirements of one individual or relatively homogeneous group. A successful relationship banking program is, therefore, dependent in a large part on the development of a series of "financial-serviced packages": each designed to meet the needs of identifiable homogeneous groups.
Another dimension of relationship banking is the development of highly personalized relationships between employee and client. In most financial institutions today the client is serviced by any employee who happens to be free at the time, regardless of the nature of the transaction. Personalized relation ships are therefore difficult to establish. In a full relationship banking pro gram, however, the client knows there is one individual within the institution who has intimate knowledge of the client's requirements and preferences regarding complex transactions. Over time, the client develops a high level of confidence in this employee. In short, a personalized relationship evolves between client and employee.
With what subject is the passage mainly concerned?
A.The decline of the financial-service industry.
B.Variety within financial services.
C.A way of making banking more personal.
D.Increasing everyday banking transactions.
第2题
关于纤溶酶原,错误的是
A、主要由肝脏合成
B、属于优球蛋白成分
C、天然纤溶酶原称为谷氨酸纤溶酶原
D、纤溶酶原不容易被纤维蛋白吸附
E、以酶原形式存在于血液中
第3题
B、链激酶
C、维生素K
D、氨甲苯酸
E、垂体后叶素
激动纤溶酶原激活酶,促进纤溶酶原转变成纤溶酶,表现纤溶作用的药物是A、鱼精蛋白
B、链激酶
C、维生素K
D、氨甲苯酸
E、垂体后叶素
第4题
根据下列材料,请回答下列各题:
抑制或激动纤溶酶原激活酶,影响纤溶酶原转变成纤溶酶,表现出溶栓或抗纤溶作用。临床适用纤维蛋白溶解活性增高的出血、急性血栓栓塞性疾病、深部静脉血栓形成。
抑制纤溶酶原激活酶,使纤溶酶原无法转变成纤溶酶,表现抗纤溶作用的药物是
A.鱼精蛋白
B.链激酶
C.维生素K
D.氨甲苯酸
E.垂体后叶素
第5题
氨甲环酸的作用是
A.对抗纤溶酶原激活因子
B.抑制纤溶酶原
C.促进肝脏合成凝血酶原
D.增加血小板聚集
E.促使毛细血管收缩
第6题
肝硬化患者出血倾向的最主要原因是
A.毛细血管脆性增加
B.凝血因子合成障碍
C.维生素K缺乏
D.肝脏解毒功能不良而致毒性反应
E.血小板功能不良
第7题
血浆纤溶酶原水平增高与下列哪项有关
A、纤溶活性增高
B、纤溶活性下降
C、DIC
D、肝脏疾病
E、出血性疾病
第8题
链激酶的作用机制
A、对抗维生素K
B、使纤溶酶原变为纤溶酶
C、激活抗凝血酶Ⅲ
D、拮抗钙离子
E、抑制肝合成凝血因子
为了保护您的账号安全,请在“上学吧”公众号进行验证,点击“官网服务”-“账号验证”后输入验证码“”完成验证,验证成功后方可继续查看答案!